Vesicular Monoamine Transporter 2 Inhibitors

Name
Vesicular Monoamine Transporter 2 Inhibitors
Accession Number
DBCAT004435
Description

Not Available

Drugs
DrugDrug Description
TetrabenazineA vesicular monoamine transporter 2 (VMAT) inhibitor used for the management of chorea associated with Huntington's Disease.
ValbenazineA vesicular monoamine transporter 2 inhibitor used to treat tardive dyskinesia and chorea associated with Huntington's disease.
DeutetrabenazineA vesicular monoamine transporter 2 inhibitor used for the symptomatic treatment of tardive dyskinesia and chorea associated with Huntington's disease.
Drugs & Drug Targets
DrugTargetType
TetrabenazineSynaptic vesicular amine transportertarget
TetrabenazineCytochrome P450 2D6enzyme
TetrabenazineDopamine D2 receptortarget
TetrabenazineCarbonyl reductase [NADPH] 1enzyme
ValbenazineSynaptic vesicular amine transportertarget
ValbenazineCytochrome P450 2D6enzyme
ValbenazineCytochrome P450 3A4enzyme
ValbenazineCytochrome P450 3A5enzyme
DeutetrabenazineSynaptic vesicular amine transportertarget
DeutetrabenazineCarbonyl reductase [NADPH] 1enzyme
DeutetrabenazineCarbonyl reductase [NADPH] 3enzyme
DeutetrabenazineCytochrome P450 2D6enzyme
DeutetrabenazineCytochrome P450 1A2enzyme
DeutetrabenazineCytochrome P450 3A5enzyme
DeutetrabenazineCytochrome P450 3A4enzyme